Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
Huashan Hospital Affiliated to Fudan University, Shanghai Huashan Hospital Affiliated to Fudan University, Shanghai